全文获取类型
收费全文 | 8550篇 |
免费 | 625篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 124篇 |
儿科学 | 241篇 |
妇产科学 | 210篇 |
基础医学 | 1083篇 |
口腔科学 | 177篇 |
临床医学 | 1021篇 |
内科学 | 1798篇 |
皮肤病学 | 119篇 |
神经病学 | 848篇 |
特种医学 | 387篇 |
外科学 | 1385篇 |
综合类 | 58篇 |
一般理论 | 3篇 |
预防医学 | 561篇 |
眼科学 | 114篇 |
药学 | 454篇 |
中国医学 | 37篇 |
肿瘤学 | 583篇 |
出版年
2023年 | 48篇 |
2022年 | 76篇 |
2021年 | 186篇 |
2020年 | 122篇 |
2019年 | 196篇 |
2018年 | 225篇 |
2017年 | 178篇 |
2016年 | 183篇 |
2015年 | 231篇 |
2014年 | 315篇 |
2013年 | 369篇 |
2012年 | 590篇 |
2011年 | 591篇 |
2010年 | 335篇 |
2009年 | 303篇 |
2008年 | 528篇 |
2007年 | 543篇 |
2006年 | 523篇 |
2005年 | 538篇 |
2004年 | 594篇 |
2003年 | 522篇 |
2002年 | 448篇 |
2001年 | 57篇 |
2000年 | 70篇 |
1999年 | 77篇 |
1998年 | 107篇 |
1997年 | 101篇 |
1996年 | 80篇 |
1995年 | 82篇 |
1994年 | 69篇 |
1993年 | 58篇 |
1992年 | 56篇 |
1991年 | 40篇 |
1990年 | 34篇 |
1989年 | 43篇 |
1988年 | 31篇 |
1987年 | 29篇 |
1986年 | 34篇 |
1985年 | 35篇 |
1984年 | 48篇 |
1983年 | 43篇 |
1982年 | 52篇 |
1981年 | 52篇 |
1980年 | 45篇 |
1979年 | 24篇 |
1978年 | 35篇 |
1977年 | 38篇 |
1976年 | 21篇 |
1975年 | 20篇 |
1973年 | 32篇 |
排序方式: 共有9203条查询结果,搜索用时 15 毫秒
61.
Close Carolina Elek Elvira Roberts Cheryl A. Dunlap Laura J. Graham Phillip W. Scaglione Nichole M. Palen Lori-Ann Clarke Thomas 《Prevention science》2021,22(8):1071-1085
Prevention Science - This prospective cost analysis addresses a gap in the prevention literature by providing estimates of the typical real-world costs to implement community interventions focused... 相似文献
62.
63.
Joseph G. Cheaib Lauren E. Claus Hiten D. Patel Max R. Kates Andres Matoso Noah M. Hahn Trinity J. Bivalacqua Jean H. Hoffman-Censits Phillip M. Pierorazio 《Urologic oncology》2021,39(1):74.e9-74.e16
PurposeMetastatic recurrence occurs in over 25% of upper tract urothelial carcinoma patients treated with radical nephroureterectomy. While metastatic recurrence suggests poor prognosis, the impact of the specific site of recurrence on prognosis is not well documented.Materials and methodsWe retrospectively analyzed 188 patients who underwent radical nephroureterectomy for high-grade, node-negative upper tract urothelial carcinoma at our institution from 2003 to 2018 without receiving neoadjuvant or adjuvant chemotherapy. Competing-risks survival analysis was performed to evaluate the cumulative incidence and predictors of metastatic recurrence. The Kaplan-Meier method and log-rank test were used to estimate and compare recurrence site-specific survival probabilities following metastatic recurrence. Cox regression analyses were performed to assess site-specific prognoses.ResultsOf the 188 patients, 47 (25%) developed metastatic recurrence over a median follow-up of 30 months (interquartile range: 10.5–58.5 months). The 1- and 2-year cumulative incidences of metastatic recurrence were 13.6% and 23.6%, respectively. On multivariable analysis, lymphovascular invasion was significantly predictive of metastatic recurrence (subhazard ratio: 2.6, P = 0.01). Of the 47 patients who developed recurrence, 38 (80.9%) died over a median follow-up of 10 months (interquartile range: 5–20 months). Metastatic recurrence was most common in the lungs (n= 13, 28%) and at multiple sites (n= 14, 30%). Median time to recurrence was shorter for recurrences at multiple sites (6.5 months) and those in the liver (13 months) and bone (18 months) compared to other sites. Patients who recurred in the liver (hazard ratio: 6.3, P = 0.007), bone (hazard ratio: 4.9, P = 0.02), and multiple sites (hazard ratio: 4.6, P = 0.01) had significantly worse prognosis compared to those who recurred in lymph nodes. Statistical significance persisted after adjusting for treatment with salvage therapy.ConclusionsA significant proportion of high-grade upper tract urothelial carcinoma patients recur systemically after radical nephroureterectomy. Lymphovascular invasion is a predictor of metastatic recurrence and may inform decisions regarding perioperative chemotherapy. Hepatic and osseous recurrences have relatively quicker onset and less favorable prognosis compared to other sites. These findings may benefit future efforts to develop recurrence site-specific treatment plans and highlight the necessity of subsequent endeavors to explore the genetic associations of recurrence in upper tract urothelial carcinoma. 相似文献
64.
Rohit R. Badia Solomon Woldu Hiten D. Patel Nirmish Singla Arnav Srivastava Joseph G. Cheaib Phillip M. Pierorazio Aditya Bagrodia 《Urologic oncology》2021,39(2):136.e19-136.e25
BackgroundThe American Joint Committee on Cancer 8th edition staging guidelines for testicular cancer established a 3 cm cutoff to subclassify stage T1 seminomas (<3 cm = pT1a and ≥3 cm = pT1b). The efficacy of this cutoff in predicting metastatic disease and impact on treatment patterns have not been studied.MethodsWe retrospectively reviewed patients with pT1 testicular seminoma in the National Cancer Database from 2004 to 2016. Receiver operating curves were used to determine the efficacy of the 3 cm tumor cutoff in identifying metastatic disease, and multivariable regression was used to compute the effect of tumor size on the rate of adjuvant therapy among Stage I patients.ResultsA total of 10,134 patients with pT1 seminoma were evaluated. The current size cutoff of 3 cm for subclassification did not exhibit high discrimination in identifying metastatic disease (area under receiver operating curve: 0.546). Surveillance has grown as the preferred treatment after orchiectomy ?32.1% in 2004 to 81.2% in 2015. However, the rate of adjuvant therapy for pT1, Stage I seminomas associated positively with tumor size even with adjustment for year of diagnosis. For tumors above 3 cm, the odds ratio stabilized around 1.9. By using the 3 cm cutoff to guide adjuvant therapy, up to 85% of T1b patients may be overtreated.ConclusionThe 3 cm cutoff for subclassification of Stage I seminoma does not predict metastatic recurrence but is associated with increased receipt of adjuvant therapy. A 3 cm cutoff and the pT1a/b classification may therefore contribute to overtreatment in many young patients with a long life expectancy for whom minimizing adverse effects should be prioritized. 相似文献
65.
Phillip S. Gordon Gary J. Farkas David R. Gater Jr 《Topics in spinal cord injury rehabilitation》2021,27(1):36
The population with SCI is at a significant risk for both insulin resistance and type 2 diabetes mellitus (T2DM) secondary to neurogenic obesity. The prevalence of insulin resistance and T2DM in persons with SCI suggests that disorders of carbohydrate metabolism are at epidemic proportions within the population. However, the true frequency of such disorders may be underestimated because biomarkers of insulin resistance and T2DM used from the population without SCI remain nonspecific and may in fact fail to identify true cases that would benefit from intervention. Furthermore, diet and exercise have been used to help mitigate neurogenic obesity, but results on disorders of carbohydrate metabolism remain inconsistent, likely because of the various ways carbohydrate metabolism is assessed. The objective of this article is to review current literature on the prevalence and likely mechanisms driving insulin resistance and T2DM in persons with SCI. This article also explores the various assessments and diagnostic criteria used for insulin resistance and T2DM and briefly discusses the effects of exercise and/or diet to mitigate disorders of carbohydrate metabolism brought on by neurogenic obesity. 相似文献
66.
67.
Francesca Di Giallonardo Angie N Pinto Phillip Keen Ansari Shaik Alex Carrera Hanan Salem Christine Selvey Steven J Nigro Neil Fraser Karen Price Joanne Holden Frederick J Lee Dominic E Dwyer Benjamin R Bavinton Jemma L Geoghegan Andrew E Grulich Anthony D Kelleher the NSW HIV Prevention Partnership Project 《Journal of the International AIDS Society》2021,24(1)
IntroductionThe human immunodeficiency virus 1 (HIV‐1) pandemic is characterized by numerous distinct sub‐epidemics (clusters) that continually fuel local transmission. The aims of this study were to identify active growing clusters, to understand which factors most influence the transmission dynamics, how these vary between different subtypes and how this information might contribute to effective public health responses.MethodsWe used HIV‐1 genomic sequence data linked to demographic factors that accounted for approximately 70% of all new HIV‐1 notifications in New South Wales (NSW). We assessed differences in transmission cluster dynamics between subtype B and circulating recombinant form 01_AE (CRF01_AE). Separate phylogenetic trees were estimated using 2919 subtype B and 473 CRF01_AE sequences sampled between 2004 and 2018 in combination with global sequence data and NSW‐specific clades were classified as clusters, pairs or singletons. Significant differences in demographics between subtypes were assessed with Chi‐Square statistics.ResultsWe identified 104 subtype B and 11 CRF01_AE growing clusters containing a maximum of 29 and 11 sequences for subtype B and CRF01_AE respectively. We observed a > 2‐fold increase in the number of NSW‐specific CRF01_AE clades over time. Subtype B clusters were associated with individuals reporting men who have sex with men (MSM) as their transmission risk factor, being born in Australia, and being diagnosed during the early stage of infection (p < 0.01). CRF01_AE infections clusters were associated with infections among individuals diagnosed during the early stage of infection (p < 0.05) and CRF01_AE singletons were more likely to be from infections among individuals reporting heterosexual transmission (p < 0.05). We found six subtype B clusters with an above‐average growth rate (>1.5 sequences / 6‐months) and which consisted of a majority of infections among MSM. We also found four active growing CRF01_AE clusters containing only infections among MSM. Finally, we found 47 subtype B and seven CRF01_AE clusters that contained a large gap in time (>1 year) between infections and may be indicative of intermediate transmissions via undiagnosed individuals.ConclusionsThe large number of active and growing clusters among MSM are the driving force of the ongoing epidemic in NSW for subtype B and CRF01_AE. 相似文献
68.
Eight elderly patients (mean age +/- SD, 73.2 +/- 9.5 years) were studied with Holter electrocardiographic monitoring for 24 h before and 24 h after an electroconvulsive therapy (ECT) treatment. Patients with a history of cardiac disease but who were not experiencing any active cardiac symptoms were chosen for study. They were not receiving either cardioactive medications or psychotropic agents that can effect cardiac rhythm or conduction. Each patient served as his own control, with direct comparison of the periods before and after the treatment. There were no differences before and after ECT in the electrocardiogram. One minute after the seizure, patients were hypertensive and tachycardic. ECT does not appear to pose additional risk in stable, elderly patients with a history of cardiac disease. 相似文献
69.
Reactions to radiocontrast material 总被引:1,自引:0,他引:1
70.
Charles M. Holman Jr. M.D. Phillip G. Arnold M.D. Maurice J. Jurkiewicz M.D. Kenneth N. Walton M.D. 《Urology》1977,10(6):576-578
The surgical rehabilitation of a patient with severely deformed and functionally disabled genitalia due to long-standing lymphedema and infection is described and illustrated. The term "elephantiasis" has been applied to such gross lesions. Appropriate surgery to the penis, scrotum, and perineum has yielded a gratifying result. The principles and techniques of the surgical approach in such an undertaking are presented and discussed. 相似文献